Wittenauer Rachel, Wu Linxuan, Cox Sarah, Pfau Brian, Sharma Monisha
Department of Pharmacy, University of Washington, Seattle, Washington, USA
Department of Epidemiology, University of Washington School of Public Health, Seattle, Washington, USA.
BMJ Glob Health. 2025 Jan 11;10(1):e015835. doi: 10.1136/bmjgh-2024-015835.
Oral pre-exposure prophylaxis (PrEP) is a priority intervention for scale-up in countries with high HIV prevalence. Policymakers must decide how to optimise PrEP allocation to maximise health benefits within limited budgets. We assessed the health and economic impact of PrEP scale-up among different subgroups and regions in western Kenya.
We adapted an agent-based network model, EMOD-HIV, to simulate PrEP uptake in six counties of western Kenya across seven subgroups including serodiscordant couples (SDCs), adolescent girls and young women (AGYW), adolescent boys and young men, women with multiple partners and men with multiple partners. We modelled 5 years of PrEP provision assuming 90% PrEP uptake in the prioritised subgroups and evaluated outcomes over 20 years compared with a no PrEP scenario. All results are presented in 2021 USD$.
Population PrEP coverage was highest in the broad AGYW scenario (8.3%, ~2 fold higher than the next highest coverage scenario) and lowest in the SDC scenario (0.37%). Across scenarios, PrEP averted 4.5%-21.3% of infections over the 5-year implementation. PrEP provision to SDCs was associated with the lowest incremental cost-effectiveness ratio (ICER), $245 per disability-adjusted life year (DALY) averted (CI $179 to $435), followed by women and men with multiple partners ($1898 (CI $1002 to $6771) and $2351 (CI $1 831 to $3494) per DALY averted, respectively). Targeted strategies were more efficient than broad provision even in high HIV prevalence counties; PrEP scale-up for AGYW with multiple partners had an ICER per DALY averted of $4745 (CI $2059 to $22 515) compared with $12 351 for broad AGYW (CI $7 050 to $33,955). In general, ICERs were lower in counties with higher HIV prevalence.
PrEP scale-up can avert substantial HIV infections and increasing PrEP demand for subgroups at higher risk can increase efficiency of PrEP programmes. Our results on health and cost impact of PrEP across geographic regions in western Kenya can be used for budgetary planning and priority setting.
口服暴露前预防(PrEP)是在艾滋病毒高流行国家扩大规模的一项优先干预措施。政策制定者必须决定如何优化PrEP的分配,以便在有限预算内实现最大的健康效益。我们评估了在肯尼亚西部不同亚组和地区扩大PrEP规模对健康和经济的影响。
我们采用了一种基于主体的网络模型EMOD-HIV,来模拟肯尼亚西部六个县七个亚组(包括血清学不一致的夫妻(SDC)、青春期女孩和年轻女性(AGYW)、青春期男孩和年轻男性、有多个性伴侣的女性和有多个性伴侣的男性)中PrEP的使用情况。我们模拟了5年的PrEP供应情况,假设优先亚组中有90%的人使用PrEP,并与不使用PrEP的情况相比,评估了20年的结果。所有结果均以2021年美元呈现。
在广泛的AGYW情景中,人群PrEP覆盖率最高(8.3%,比第二高覆盖率情景高约2倍),在SDC情景中最低(0.37%)。在所有情景中,PrEP在5年实施期间避免了4.5%-21.3%的感染。向SDC提供PrEP的增量成本效益比(ICER)最低,每避免一个伤残调整生命年(DALY)为245美元(可信区间为179美元至435美元),其次是有多个性伴侣的女性和男性(每避免一个DALY分别为1898美元(可信区间为1002美元至6771美元)和2351美元(可信区间为1831美元至3494美元))。即使在艾滋病毒高流行县,针对性策略也比广泛提供更有效;与广泛的AGYW情景(每避免一个DALY的ICER为12351美元(可信区间为7050美元至33955美元))相比,为有多个性伴侣的AGYW扩大PrEP规模,每避免一个DALY的ICER为4745美元(可信区间为2059美元至22515美元)。一般来说,艾滋病毒流行率较高的县的ICER较低。
扩大PrEP规模可避免大量艾滋病毒感染,增加对高风险亚组的PrEP需求可提高PrEP项目的效率。我们关于PrEP在肯尼亚西部不同地理区域对健康和成本影响的结果可用于预算规划和确定优先事项。